|Table of Contents|

Disease burden of lung cancer attributable to smoking in China from 1990 to 2019

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2024 01
Page:
141-146
Research Field:
Publishing date:

Info

Title:
Disease burden of lung cancer attributable to smoking in China from 1990 to 2019
Author(s):
DING LuluZHU JianZHANG YonghuiXU YuanyouCHEN YongshengWANG Jun
Qidong People's Hospital,Qidong Liver Cancer Institute,the Affiliated Qidong Hospital of Nantong University,Jiangsu Qidong 226200,China.
Keywords:
lung cancersmokingdisease burdenChina
PACS:
R734.2
DOI:
10.3969/j.issn.1672-4992.2024.01.026
Abstract:
Objective:To analyze the disease burden of lung cancer attributable to smoking in China from 1990 to 2019 in order to provide reference for the prevention and control of lung cancer.Methods:Based on the data of global burden of disease 2019(GBD2019),the data of lung cancer attributable to smoking from 1990 to 2019 were selected.Population attributable fraction(PAF),crude mortality and disability adjusted life year(DALY) were used to analyze the disease burden of lung cancer attributable to smoking in China,the annual percent change(APC) was calculated by Joinpoint Regression 4.7.0.0.Results:PAF of lung cancer attributable to smoking in China increased from 58.16% in 1990 to 62.06% in 2019,and the standardized mortality rate increased from 18.99/105 in 1990 to 24.94/105 in 2019,and the standardized DALY rate increased from 442.84/105 in 1990 to 516.48/105 in 2019.In 1990,the standardized mortality rate and standardized DALY rate of lung cancer attributable to smoking were 37.27/105 and 837.55/105 for male,3.64/105 and 70.21/105 for female respectively in China.In 2019,the standardized mortality rate and the standardized DALY rate of lung cancer attributable to smoking were 47.66/105 and 961.58/105 for male,6.08/105 and 107.97/105 for female,respectively.Mortality rate and DALY rate increased with the increase of age.In 2019,the age group of mortality rate and DALY rate peaked at 85+years(319.25/105) and 75~79 years(3 902.13/105),respectively,one age group later than 1990.Compared with 1990,the mortality rate and DALY rate of lung cancer attributable to smoking increased significantly in the age groups over 70 years old,but decreased in age groups under 60 years old.In the past 30 years,the standardized mortality rates and standardized DALY rates in China have experienced three stages of increase,stabilization and decrease,in which 2010-2019 was the declining stage,with APC values of-0.715% and-0.864% respectively,but still higher than the global level.Conclusion:The disease burden of lung cancer attributable to smoking is serious in China from 1990 to 2019,and the males and the elderly are the high-risk groups.The targeted intervention measures should be further adopted to reduce the disease burden of lung cancer attributable to smoking.

References:

[1]SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2]MAO Y,YANG D,HE J,et al.Epidemiology of lung cancer[J].Surgoncolclin N Am,2016,25(3):439-445.
[3]IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.Tobacco smoke and involuntary smoking[J].IARC Monogr Eval Carcinog Risks Hum,2004,83:1.
[4]Global Burden of Disease Collaborative Network.Global Burden of Disease Study 2019 results [EB/OL].(2020-10-15)[2023-01-22].http://ghdx.healthdata.org/gbd-results-tool.
[5]GBD 2019 Stroke Collaborators.Global,regional,and national burden of stroke and its risk factors,1990-2019:A systematic analysis for the global burden of disease study 2019[J].Lancet Neurol,2021,20(10):795-820.
[6]GBD 2019 Diseases and Injuries Collaborators.Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:A systematic analysis for the global burden of disease study 2019[J].Lancet,2020,396(10258):1204-1222.
[7]中国疾病预防控制中心慢性非传染性疾病预防控制中心.中国死因监测数据集.2019[M].北京:中国科学技术出版社,2020:10. NCNCD of CDC.Chinese Center for Disease Control and Prevention.China's death cause monitoring data set(2019)[M].Beijing:China Science and Technology Press,2020:10.
[8]GBD 2019 Risk Factors Collaborators.Global burden of 87 risk factors in 204 countries and territories,1990-2019:A systematic analysis for the global burden of disease study 2019[J].Lancet,2020,396(10258):1223-1249.
[9]Division of Cancer Control and Population Sciences NCL.Joinpointtrend analysis software[EB/OL].[2023-01-30].https://surveillance.cancer.gov/joinpoint/.
[10]路友华,王炳翔,王家林,等.中国居民1990-2019年肺癌及其危险因素疾病负担变化趋势分析[J].中国公共卫生,2022,38(5):513-517. LU YH,WANG BX,WANG JL,et al.Changing trend in disease burden of lung cancer and its risk factors among Chinese residents,1990-2019[J].Chinese Journal of Public Health,2022,38(5):513-517.
[11]江雨琛,俞浩,罗鹏飞,等.1990-2019年江苏省肺癌疾病负担及其危险因素变化趋势研究[J].中国肿瘤,2022,31(5):327-334. JIANG YC,YU H,LUO PF,et al.Trends of burden on lung cancer and related risk factors in Jiangsu Province from 1990 to 2019[J].China Cancer,2022,31(5):327-334.
[12]丁贤彬,吕晓燕,焦艳,等.2019年重庆市30岁及以上人群归因于吸烟的肺癌疾病负担研究[J].中国慢性病预防与控制,2022,30(8):578-581. DING XB,LYU XY,JIAO Y,et al.Analysis on disease burden of lung cancer attributable to smoking among residents(≥30 years old) of Chongqing in 2019[J].Chinese Journal of Prevention and Control of Chronic Diseases,2022,30(8):578-581.
[13]李新华.2018年中国成人烟草调查报告[M].北京:人民卫生出版社,2020:1-2. LI XH.China adult tobacco survey report 2018[M].Beijing:People's Health Publishing House,2020:1-2.
[14]YU Y,LIU H,ZHENG S,et al.Gender susceptibility for cigarette smoking-attributable lung cancer:A systematic review and Meta-analysis[J].Lung Cancer,2014,85(3):351-360.
[15]倪雪,许宁,王强.基于贝叶斯时空模型探究中国女性肺癌发病风险及其影响因素[J].环境卫生学杂志,2022,12(6):407-414. NI X,XU N,WANG Q.Analysis on the incidence risk and their influence factors of female lung cancer in China based on Bayesian spatio-temporal model[J].Journal of Environmental Hygiene,2022,12(6):407-414.
[16]TURNER MC,ANDERSEN ZJ,BACCARELLI A,et al.Outdoor air pollution and cancer:An overview of the currentevidence and public health recommendations[J].CA Cancer J Clin,2020,70(6):460-479.
[17]BADE BC,DELA CRUZ CS.Lung cancer 2020:Epidemiology,etiology,and prevention[J].Clin Chest Med,2020,41(1):1-24.
[18]项鑫,王乙.中国人口老龄化现状、特点、原因及对策[J].中国老年学杂志,2021,41(18):4149-4152. XIANG X,WANG Y.The current situation,characteristics,causes,and countermeasures of China's aging population[J].Chinese Journal of Gerontology,2021,41(18):4149-4152.
[19]WHO.WHO global report on trends in prevalence of tobaccosmoking 2000-2025.2nd ed[Z/OL].[2023-02-20].https://apps.who.int/iris/handle/10665/272694.
[20]邹小农,贾漫漫,王鑫,等.中国肺癌和烟草流行及控烟现状[J].中国肺癌杂志,2017,20(8):505-510. ZOU XN,JIA MM,WANG X,et al.Changing epidemic of lung cancer & tobacco and situation of tobacco control in China[J].Chinese Journal of Lung Cancer,2017,20(8):505-510.
[21]国家卫生健康委,国家发展改革委,教育部,等.健康中国行动—癌症防治实施方案(2019-2022年)[J].中国肿瘤,2019,28(11):803-806. National Health and Wellness Commission,National Development and Reform Commission,Ministry of Education,et al.Health China Action—Cancer Prevention and Control Implementation Plan(2019-2022)[J].China Cancer,2019,28(11):803-806.

Memo

Memo:
-
Last Update: 2023-11-30